Vidal-Moren, James D.
18  Ergebnisse:
Personensuche X
?
5

Comparative efficacy and safety of rimegepant, ubrogepant, ..:

Johnston, Karissa ; Popoff, Evan ; Deighton, Alison...
Expert Review of Pharmacoeconomics & Outcomes Research.  22 (2021)  1 - p. 155-166 , 2021
 
?
6

Matching‐adjusted indirect comparisons of oral rimegepant v..:

Popoff, Evan ; Johnston, Karissa ; Croop, Robert...
Headache: The Journal of Head and Face Pain.  61 (2021)  6 - p. 906-915 , 2021
 
?
7

Emerging technologies in brachytherapy:

Song, William Y ; Robar, James L ; Morén, Björn...
Physics in Medicine & Biology.  66 (2021)  23 - p. 23TR01 , 2021
 
?
8

Proteomic and lipidomic analyses of paraoxonase defined hig..:

Moren, Xenia ; Lhomme, Marie ; Bulla, Alexandre...
PROTEOMICS – Clinical Applications.  10 (2015)  3 - p. 230-238 , 2015
 
?
9

Mitochondrial and apoptoticin vitromodelling of differentia..:

Morén, C. ; Bañó, M. ; González-Casacuberta, I....
Journal of Antimicrobial Chemotherapy.  70 (2015)  8 - p. 2330-2336 , 2015
 
?
10

HDL subfraction distribution of paraoxonase-1 and its relev..:

Moren, Xenia ; Deakin, Sara ; Liu, Ming-Lin..
Journal of Lipid Research.  49 (2008)  6 - p. 1246-1253 , 2008
 
?
11

Mitochondrial toxicity of antiretrovirals in non-HIV-infect..:

Garrabou, G ; Pedrol, E ; Deig, E...
Journal of the International AIDS Society.  11 (2008)  Suppl 1 - p. P146 , 2008
 
?
 
?
14

Postprandial modulation of serum paraoxonase activity and c..:

Beer, Sandra ; Moren, Xenia ; Ruiz, Juan.
Nutrition, Metabolism and Cardiovascular Diseases.  16 (2006)  7 - p. 457-465 , 2006
 
1-15